Skip to main content

Table 1 General characteristics of the study patients at baseline

From: Outcome of patients with septic shock and high-dose vasopressor therapy

Variables All (n = 106) Survivors at day 28 (n = 42) Non-survivors at day 28 (n = 64) p
Age (years), mean ± SD 62 ± 16 63 ± 14 59 ± 19 0.81
Sex [n (%)]     
 Males 75 (70.8) 32 (76.2) 43 (67.2) 0.32
Comorbidities [n (%)]     
 Immunosuppression 35 (33) 12 (28.6) 23 (35.9) 0.43
 Cardiovascular disease 31 (29.2) 12 (28.6) 19 (29.7) 0.90
 Respiratory disease 17 (16) 7 (16.7) 10 (15.6) 0.36
 Renal disease 14 (13.2) 5 (11.9) 9 (14.1) 0.75
 Obesity 15 (14.2) 8 (19.0) 7 (10.9) 0.24
 Cirrhosis 12 (11.3) 1 (2.4) 11 (17.2) 0.03
 Diabetes mellitus 30 (28.3) 13 (31.0) 17 (26.6) 0.62
Source of infection [n (%)]     
 Community-acquired 55 (51.9) 25 (59.5) 30 (46.9) 0.20
 Hospital-acquired 51 (41.1) 17 (40.5) 34 (53.1) 0.20